Found: 31
Select item for more details and to access through your institution.
Leucine-sensitive hyperinsulinaemic hypoglycaemia in patients with loss of function mutations in 3-Hydroxyacyl-CoA Dehydrogenase.
- Published in:
- Orphanet Journal of Rare Diseases, 2012, v. 7, n. 1, p. 25, doi. 10.1186/1750-1172-7-25
- By:
- Publication type:
- Article
Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 8, p. 3232, doi. 10.1093/brain/awad105
- By:
- Publication type:
- Article
Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotype.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Neurofilament light predicts neurological outcome after subarachnoid haemorrhage.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Subacute plasma neurofilament light predicts neurodegeneration after moderate‐severe traumatic brain injury.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052522
- By:
- Publication type:
- Article
Serum neurofilament light and whole brain volume associate with machine‐learning derived brain‐predicted age in the British 1946 birth cohort: Neuroimaging / New imaging methods.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045965
- By:
- Publication type:
- Article
Plasma phospho‐tau in familial Alzheimer's disease: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042921
- By:
- Publication type:
- Article
Microglial activation: A process potentially related to Alzheimer's disease and late‐life major depression: Biomarkers (non‐neuroimaging)/Prognostic utility.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041950
- By:
- Publication type:
- Article
Plasma phospho‐tau181 in over 400 cognitively healthy 69‐ to 71‐year‐olds: Associations with cerebral amyloid, structural imaging and cognition in the Insight 46 study: Biomarkers (non‐neuroimaging): Multimodal biomarker studies in cognitively unimpaired cohorts
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.037848
- By:
- Publication type:
- Article
P3‐234: PLASMA AMYLOID, TAU AND SERUM NEUROFILAMENT LIGHT CHAIN IN INSIGHT 46: ASSOCIATIONS WITH COGNITION AND BRAIN IMAGING.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1023, doi. 10.1016/j.jalz.2019.06.3264
- By:
- Publication type:
- Article
P2‐244: NEUROFILAMENT LIGHT IN ISOPOTENTIAL STEM CELL‐DERIVED NEURONS WITH FAMILIAL AD MUTATIONS AS A MARKER OF NEURODEGENERATION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P676, doi. 10.1016/j.jalz.2019.06.2651
- By:
- Publication type:
- Article
P2‐237: IMMUNOHISTOCHEMICAL PROFILING OF PRIMARY TAUOPATHIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P671, doi. 10.1016/j.jalz.2019.06.2644
- By:
- Publication type:
- Article
O1‐03‐04: CORTICAL NEURONS AND CEREBRAL ORGANOIDS FROM APP AND PSEN1 MUTATION CARRIERS REVEAL MUTATION‐SPECIFIC EFFECTS ON Aβ PRODUCTION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P199, doi. 10.1016/j.jalz.2019.06.4532
- By:
- Publication type:
- Article
F1‐05‐03: THE 1946 COHORT: RELATIONSHIPS BETWEEN CEREBRAL AMYLOID PATHOLOGY USING TWO INDEPENDENT METHODS FOR PLASMA AMYLOID BETA MEASUREMENT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P185, doi. 10.1016/j.jalz.2019.06.4387
- By:
- Publication type:
- Article
Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, p. 1, doi. 10.1186/s13195-018-0361-3
- By:
- Publication type:
- Article
DISTINCT Aβ PRODUCTION IN STEM CELL-DERIVED CORTICAL NEURONS FROM PATIENTS WITH FAD MUTATION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P311, doi. 10.1016/j.jalz.2017.06.247
- By:
- Publication type:
- Article
BIOMARKERS OF INFLAMMATION IN ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P215, doi. 10.1016/j.jalz.2017.07.090
- By:
- Publication type:
- Article
SERUM FERRITIN IS INCREASED IN A SUBSET OF PATIENTS WITH FRONTOTEMPORAL DEMENTIA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P710, doi. 10.1016/j.jalz.2017.06.906
- By:
- Publication type:
- Article
Microglial-derived proteins in CSF are candidate biomarkers for early diagnosis of Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P126, doi. 10.1016/j.jalz.2015.07.033
- By:
- Publication type:
- Article
Development of a targeted proteomic multiplex CSF assay for neurodegenerative markers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P645, doi. 10.1016/j.jalz.2015.06.942
- By:
- Publication type:
- Article
Differences in the TREM2 levels in the CSF of Alzheimer’s disease cases and controls.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P511, doi. 10.1016/j.jalz.2015.06.611
- By:
- Publication type:
- Article
Amyloid processing in COVID‐19‐associated neurological syndromes.
- Published in:
- Journal of Neurochemistry, 2022, v. 161, n. 2, p. 146, doi. 10.1111/jnc.15585
- By:
- Publication type:
- Article
Plasma Markers of Neurodegeneration Are Raised in Friedreich's Ataxia.
- Published in:
- Frontiers in Cellular Neuroscience, 2018, p. 1, doi. 10.3389/fncel.2018.00366
- By:
- Publication type:
- Article
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 3, p. 377, doi. 10.1001/jamaneurol.2019.4347
- By:
- Publication type:
- Article
Neuroimaging and plasma evidence of early white matter loss in Parkinson's disease with poor outcomes.
- Published in:
- Brain Communications, 2024, v. 6, n. 3, p. 1, doi. 10.1093/braincomms/fcae130
- By:
- Publication type:
- Article
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes.
- Published in:
- Brain Communications, 2021, v. 3, n. 3, p. 1, doi. 10.1093/braincomms/fcab099
- By:
- Publication type:
- Article
Diabetes and Neuroaxonal Damage in Parkinson's Disease.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2024, v. 16, n. 2, p. 1, doi. 10.1002/dad2.12590
- By:
- Publication type:
- Article
Plasma metabolites distinguish dementia with Lewy bodies from Alzheimer’s disease: a cross-sectional metabolomic analysis.
- Published in:
- Frontiers in Aging Neuroscience, 2024, p. 1, doi. 10.3389/fnagi.2023.1326780
- By:
- Publication type:
- Article
Alzheimer's Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint.
- Published in:
- Frontiers in Neuroscience, 2022, v. 16, p. 1, doi. 10.3389/fnins.2022.837390
- By:
- Publication type:
- Article